Antares Stock Hits New 52-Week High (AIS)

NEW YORK ( TheStreet) -- Antares Pharma (AMEX: AIS) hit a new 52-week high Tuesday as it is currently trading at $3.03, above its previous 52-week high of $3 with 421,932 shares traded as of 10 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.

Antares has a market cap of $235 million and is part of the health care sector and health services industry. Shares are up 35% year to date as of the close of trading on Monday.

Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products.

TheStreet Ratings rates Antares as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Antares Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers